Author

K. Fragaki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Mauri-Crouzet· 1 shared B. Ropert· 1 shared C. Cochaud· 1 shared E. C. GENIN· 1 shared F. Lespinasse· 1 shared G. Auge· 1 shared S. Bannwarth· 1 shared S. Lacas-Gervais· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Mauri-Crouzet

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PathologybioRxivPreprintMay 31, 2021

SLP2/prohibitins aggregates and instability of the PHB complex are key elements in CHCHD10S59L-related disease

E. C. GENIN, S. Bannwarth, B. Ropert…·V. Paquis-Flucklinger

The paper identifies SLP2/prohibitin aggregates and PHB complex instability as key factors in CHCHD10S59L-related disease, leading to mitochondrial dysfunction and apoptosis.

DOI 10.1101/2021.05.31.446377

mouseproteomics

𝕏 PostBluesky